Ge, Y., & Zhao, Y. (2025, June). Overcoming therapeutic resistance in driver-negative NSCLC: Immunomodulatory mechanisms and clinical efficacy of Camrelizumab-chemotherapy combination in a real-world cohort. Discover Oncology.
Chicago Style (17th ed.) CitationGe, Yan, and Yang Zhao. "Overcoming Therapeutic Resistance in Driver-negative NSCLC: Immunomodulatory Mechanisms and Clinical Efficacy of Camrelizumab-chemotherapy Combination in a Real-world Cohort." Discover Oncology Jun. 2025.
MLA (9th ed.) CitationGe, Yan, and Yang Zhao. "Overcoming Therapeutic Resistance in Driver-negative NSCLC: Immunomodulatory Mechanisms and Clinical Efficacy of Camrelizumab-chemotherapy Combination in a Real-world Cohort." Discover Oncology, Jun. 2025.
Warning: These citations may not always be 100% accurate.
